One Biosciences: Scott Braunstein, Vincent Miller

One Biosciences, a company using single-cell analysis and AI for precision medicine discovery, has appointed Scott Braunstein and Vincent Miller to its board of directors.

Braunstein has served as operating partner of Aisling Capital since 2015. He has also been CEO of Marinus Pharmaceuticals since 2019 and chairman of the board since November 2022. Previously, he was chief operating officer and chief strategy officer at Pacira Pharmaceuticals.

Miller is considered a world expert in lung cancer and clinical trial design and interpretation. He previously served as physician-in-chief for EQRx. Prior to that he was chief medical officer at Foundation Medicine. Before joining Foundation, Miller spent more than 20 years in cancer patient care and research at Memorial Sloan Kettering Cancer Center.